| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.200807-1153OC |
| P698 | PubMed publication ID | 19096006 |
| P50 | author | Gabriella Sozzi | Q40930748 |
| John K. Field | Q42754256 | ||
| Luca Roz | Q42798848 | ||
| Paolo Bossi | Q43202728 | ||
| Alessandra Fabbri | Q45276556 | ||
| Francesca Andriani | Q51122531 | ||
| Carla Verri | Q57062338 | ||
| Luca Tavecchio | Q57419734 | ||
| Elisabeth Brambilla | Q70964699 | ||
| P2093 | author name string | Triantafillos Liloglou | |
| Davide Conte | |||
| Andrea Mancini | |||
| Aurelien Vesin | |||
| Christian Brambilla | |||
| Elisa Calabrò | |||
| Diego Tosi | |||
| Anna Livio | |||
| EUELC Consortium | |||
| Giuseppe Calarco | |||
| P2860 | cites work | Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 |
| The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma | Q28255650 | ||
| Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines | Q34019362 | ||
| Smoking molecular damage in bronchial epithelium | Q34963435 | ||
| Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation | Q36790428 | ||
| Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma | Q38481338 | ||
| Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung | Q44961920 | ||
| Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer | Q45240527 | ||
| Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation | Q46973128 | ||
| Fragile histidine triad (FHIT) gene abnormalities in lung cancer. | Q52552946 | ||
| Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. | Q53330184 | ||
| Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. | Q53338349 | ||
| Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. | Q53343023 | ||
| The FHIT gene 3p14.2 is abnormal in lung cancer. | Q53455201 | ||
| Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. | Q53599398 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 396-401 | |
| P577 | publication date | 2008-12-18 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project | |
| P478 | volume | 179 |
| Q34200303 | A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma |
| Q38369053 | Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis |
| Q42261678 | DNA methylation in promoter region as biomarkers in prostate cancer |
| Q36721411 | DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma |
| Q26996766 | Epigenetics of lung cancer |
| Q90370608 | Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance |
| Q39096348 | FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients. |
| Q33770934 | Fhit loss in lung preneoplasia: relation to DNA damage response checkpoint activation |
| Q50504589 | Highly selective, naked-eye and fluorescent "off-on" probe for detection of histidine/histidine-rich proteins and its application in living cell imaging |
| Q28285049 | Lung cancer epigenetics: emerging biomarkers |
| Q54274131 | Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer. |
| Q39313748 | New panel of microsatellite alterations detectable in the EBC for lung cancer prognosis. |
| Q37701692 | Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer |
| Q39007185 | Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer |
| Q89538752 | The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer |
| Q28068822 | The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review |
| Q36500848 | The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review |
| Q36457427 | The significance of epigenetic alterations in lung carcinogenesis |
| Q37728779 | Update in lung cancer and mesothelioma 2009. |
| Q54381818 | [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer]. |
Search more.